เอกสารอ้างอิง
1. Baumann TI, Herdon CM, Strickland JM. Pain management. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy a pathophysiologic approach. 9th ed. New York: McGraw-Hill Education; 2015. p. 929-30.
2. Wickersham RM, Novak KK, Horenkamp JR, McCarron SM, Schweain SL, Cash J, et al. Drug facts and comparisons. 2017 ed. Missouri: Wolters Kluwer; 2016.
3. Brooks P, Emery P, Evans JF, Fenner H, Hawkey CJ, Patrono C, et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) 1999;38:779-88.
4. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018 Feb 1;9(1):143-150.
5. Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46.
6. Solomon DH. Drug Information: Post TW, ed. UpToDate. Waltham: UpToDate; 2019.(Accessed on February 15, 2020.)
7. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011 Jan 11;342:c7086.
8. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011 Sep;8(9):e1001098.
9. Perazella MA, Buller GK. NSAID nephrotoxicity revisited: acute renal failure due to parenteral ketorolac. South Med J. 1993 Dec;86(12):1421-4. PubMed PMID: 8272928.
10. Medscape Pharmacists [Internet]. New York: WebMD; c2005-2020 [updated 2017 Oct 17; cited 2020 Feb 16]. Available from:
https://www.webmd.com/baby/pain-relievers-that-are-safe-during-pregnancy#1
11. Medscape Pharmacists [Internet]. New York: WebMD; c1994-2020 [updated 2018 Dec 13; cited 2020 Feb 29]. Available from:
https://www.medscape.com/viewarticle/906502
12. da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017 Jul 8;390(10090):e21-e33.
13. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews 2015, Issue 7. 6.
14. Smith RP, Ellis J. NSAIDs: Is newer better for dysmenorrhea?. Obg. Management 2002;14:71-81.
15. Smith RP, Kaunitz. Drug Information: Post TW, ed. UpToDate. Waltham: UpToDate; 2019.(Accessed on January 10, 2020.)
16. Budoff PW. Use of mefenamic acid in the treatment of primary dysmenorrhea. JAMA. 1979 Jun 22;241(25):2713-6.
17. American dental association: American dental association. Oral Analgesics for Acute Dental Pain[Internet]. 2019 [cited 2020 Jan 10];2:1 Available from: https://www.ada.org/en.